Ipca Labs Q4 Profit Up 14% to Rs 68 cr

1 Minute Read Listen to Article
Share:    

May 29, 2025 14:22

x
Ipca Laboratories announces 14% rise in Q4 net profit to Rs 68 crore, with revenue reaching Rs 2,247 crore. FY25 profit at Rs 738 crore.
New Delhi, May 29 (PTI) Ipca Laboratories on Thursday said its consolidated net profit increased 14 per cent to Rs 68 crore in the fourth quarter ended March 31, 2025.

The drug firm reported a net profit of Rs 60 crore during the January-March quarter of 2023-24 financial year.

During the quarter, revenue from operations rose to Rs 2,247 crore as compared to Rs 2,033 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.


Net profit stood at Rs 738 crore for 2024-25 fiscal against Rs 547 crore in FY24.

Revenue rose to Rs 8,940 crore for the last fiscal from Rs 7,705 crore a year ago.

The company said its board has recommended a final dividend of Rs 2 per share for the year ended March 31, 2025.

Shares of Ipca Laboratories were trading 0.67 per cent lower at Rs 1,485.70 apiece on the BSE.
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback